SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Credit Suisse Maintains Outperform on Abbott Laboratories, Raises Price Target to $136

Credit Suisse analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $109 to $136.

 · 
Credit Suisse analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $109 to $136.